从加利福尼亚大学的糖尿病预防计划倡议中学到的实施经验教训
Tamra Burns Loeb1, Kate Ramm2, Maryam Gholami3
1David Geffen School of Medicine at the University of California, Los Angeles, CA, USA. Tloeb@mednet.ucla.edu.
BMC public health
|October 11, 2024
概括
在大学实施糖尿病预防生活方式改变计划需要广泛的营销,方便的入学,适应性强的计划,安全的资金,经验丰富的员工,领导力支持和校园伙伴关系. 这些因素是计划成功的关键.
科学领域:
- 公共卫生 公共卫生
- 医疗保健服务研究 医疗服务研究
- 促进健康 促进健康
背景情况:
- 加利福尼亚大学的糖尿病预防计划 (UC DPP) 计划旨在减少10个校园的糖尿病和肥胖风险.
- 人们对大学环境中实施生活方式改变计划知之甚少.
研究的目的:
- 检查实施伙伴对影响UC DPP成功的因素的看法.
- 在基于大学的糖尿病预防计划 (DPP) 交付模式中识别挑战和机会.
主要方法:
- 对26名UC DPP领导人和校园领导进行了定性采访.
- 采访被转录并使用快速定性分析 (RQA) 进行分析.
主要成果:
- 确定了实施的七个关键主题:营销/招聘,招生,可适应的基于证据的计划,资金,经验丰富的员工,领导力支持和校园联系.
- 还描述了与这些主题相关的挑战.
结论:
- 这项研究提供了关于在大学环境中提供密集的生活方式改变计划的见解.
- 调查结果可以为UC DPP的努力提供信息,并指导其他大学的健康和健康计划交付.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.


